Can we predict who will thrive with brain stimulation for Parkinson's?
NCT ID NCT02360683
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study followed 700 Parkinson's patients who received deep brain stimulation to see which factors predict a meaningful improvement in quality of life after 1, 3, and 5 years. Researchers analyzed clinical, imaging, and genetic data to identify who benefits most. The goal is to personalize treatment decisions and avoid unnecessary risks or costs.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
deep brain stimulation (subthalamic nucleus)
What this could lead to
If successful, this could help doctors better select which Parkinson's patients will benefit most from deep brain stimulation, improving outcomes and reducing unnecessary risks.
What could go wrong
This is an observational analysis of existing data, not a new treatment trial. It may not identify clear predictors, and results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Hôpital NORD
Amiens, France
-
CHU Hôpital Pontchaillou
Rennes, France
-
CHU Purpan
Toulouse, France
-
CHU de Poitiers
Poitiers, France
-
CHU hôpital Nord Laennec
Nantes, France
-
Chu Ch.Nicolle
Rouen, France
-
Chu Gabriel-Montpied
Clermont-Ferrand, France
-
Devos
Lille, 59037, France
-
Fondation Ophtalmologique Adolphe de Rothschild
Paris, France
-
Hopital Pitie Salpetriere
Paris, France
-
Hôpital Central,
Nancy, France
-
Hôpital Pasteur
Nice, France
-
Hôpital Pierre Wertheimer
Bron, France
-
Hôpital de Hautepierre
Strasbourg, France
-
Hôpital de la Timone
Marseille, France